Delivery Order SPE2DR25D1106-SPE2DR26FJF2D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $2,245.21. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a contract ceiling value of $1,973.26. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count) with a ceiling value of $1,002.49. This firm fixed price delivery order is non-competitive and carries an ultimate completion date of December 19, 2025. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $1,048.97. This firm fixed price delivery order, with an ultimate completion date of December 5, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) with a ceiling value of $2,155.26 and a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The performance location is the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,185.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,129.10 and a firm fixed price structure. This competitive award, which carries no set-aside designation, is scheduled for completion by November 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF2DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count supply) with a ceiling value of $3,992.36. This is a firm fixed-price delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 29, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities. All reviewed contract awards demonstrate competitive award status with firm fixed pricing structures, reflecting the contractor's demonstrated capability to meet federal procurement requirements. This delivery order represents one of numerous pharmaceutical supply transactions executed under the company's prime indefinite delivery vehicle with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/25/25 |